Oxidative Stress and Antioxidant Defense by unknown
REVIEW ARTICLE
Oxidative Stress and Antioxidant Defense
Esra Birben PhD,1 Umit Murat Sahiner MD,1 Cansin Sackesen MD,1
Serpil Erzurum MD,2 and Omer Kalayci, MD1
Abstract: Reactive oxygen species (ROS) are produced by living
organisms as a result of normal cellular metabolism and environ-
mental factors, such as air pollutants or cigarette smoke. ROS are
highly reactive molecules and can damage cell structures such as
carbohydrates, nucleic acids, lipids, and proteins and alter their
functions. The shift in the balance between oxidants and antioxidants
in favor of oxidants is termed “oxidative stress.” Regulation of
reducing and oxidizing (redox) state is critical for cell viability,
activation, proliferation, and organ function. Aerobic organisms have
integrated antioxidant systems, which include enzymatic and non-
enzymatic antioxidants that are usually effective in blocking harmful
effects of ROS. However, in pathological conditions, the antioxidant
systems can be overwhelmed. Oxidative stress contributes to many
pathological conditions and diseases, including cancer, neurological
disorders, atherosclerosis, hypertension, ischemia/perfusion, diabe-
tes, acute respiratory distress syndrome, idiopathic pulmonary ﬁbro-
sis, chronic obstructive pulmonary disease, and asthma. In this
review, we summarize the cellular oxidant and antioxidant systems
and discuss the cellular effects and mechanisms of the oxidative
stress.
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Reactive oxygen species (ROS) are produced by livingorganisms as a result of normal cellular metabolism. At
low to moderate concentrations, they function in physiological
cell processes, but at high concentrations, they produce
adverse modiﬁcations to cell components, such as lipids, pro-
teins, and DNA.1–6 The shift in balance between oxidant/
antioxidant in favor of oxidants is termed “oxidative stress.”
Oxidative stress contributes to many pathological conditions,
including cancer, neurological disorders,7–10 atherosclerosis,
hypertension, ischemia/perfusion,11–14 diabetes, acute respi-
ratory distress syndrome, idiopathic pulmonary ﬁbrosis,
chronic obstructive pulmonary disease,15 and asthma.16–21
Aerobic organisms have integrated antioxidant systems,
which include enzymatic and nonenzymatic antioxidants
that are usually effective in blocking harmful effects of
ROS. However, in pathological conditions, the antioxidant
systems can be overwhelmed. In this review, we summarize
the cellular oxidant and antioxidant systems and regulation
of the reducing and oxidizing (redox) state in health and
disease states.
OXIDANTS
Endogenous Sources of ROS
ROS are produced from molecular oxygen as a result
of normal cellular metabolism. ROS can be divided into
2 groups: free radicals and nonradicals. Molecules containing
one or more unpaired electrons and thus giving reactivity to
the molecule are called free radicals. When 2 free radicals
share their unpaired electrons, nonradical forms are created.
The 3 major ROS that are of physiological signiﬁcance are
superoxide anion (O22.), hydroxyl radical (OH), and hydro-
gen peroxide (H2O2). ROS are summarized in Table 1.
Superoxide anion is formed by the addition of 1
electron to the molecular oxygen.22 This process is mediated
by nicotine adenine dinucleotide phosphate [NAD(P)H] oxi-
dase or xanthine oxidase or by mitochondrial electron trans-
port system. The major site for producing superoxide anion is
the mitochondria, the machinery of the cell to produce aden-
osine triphosphate. Normally, electrons are transferred
through mitochondrial electron transport chain for reduction
of oxygen to water, but approximately 1 to 3% of all electrons
leak from the system and produce superoxide. NAD(P)H
oxidase is found in polymorphonuclear leukocytes, mono-
cytes, and macrophages. Upon phagocytosis, these cells pro-
duce a burst of superoxide that lead to bactericidal activity.
Superoxide is converted into hydrogen peroxide by the action
of superoxide dismutases (SODs, EC 1.15.1.1). Hydrogen
peroxide easily diffuses across the plasma membrane. Hydro-
gen peroxide is also produced by xanthine oxidase, amino
acid oxidase, and NAD(P)H oxidase23,24 and in peroxisomes
by consumption of molecular oxygen in metabolic reactions.
In a succession of reactions called Haber–Weiss and Fenton
reactions, H2O2 can breakdown to OH2 in the presence of
transmission metals like Fe21 or Cu21.25
Fe31 1 $O2/Fe21 1O2  HaberWeiss
Fe21 1H2O2/Fe31 1OH2 1 $OH Fenton reaction
O22 itself can also react with H2O2 and generate
OH2.26,27 Hydroxyl radical is the most reactive of ROS
From the 1Pediatric Allergy and Asthma Unit, Hacettepe University School of
Medicine, Ankara, Turkey; 2Department of Pathobiology, Lerner Research
Institute, and the Respiratory Institute, Cleveland Clinic, Cleveland, OH.
The authors have no funding or conﬂicts of interest to disclose.
Correspondence to: Omer Kalayci, MD, Pediatric Allergy and Asthma Unit,
Hacettepe University School of Medicine, 06600 Ankara, Turkey.
Telephone: 190 312 305 1700. Fax: 190 312 311 2357. E-mail:
okalayci63@gmail.com.
Copyright  2012 by World Allergy Organization
WAO Journal  January 2012 9
and can damage proteins, lipids, and carbohydrates and DNA.
It can also start lipid peroxidation by taking an electron from
polyunsaturated fatty acids.
Granulocytic enzymes further expand the reactivity of
H2O2 via eosinophil peroxidase and myeloperoxidase
(MPO). In activated neutrophils, H2O2 is consumed by
MPO. In the presence of chloride ion, H2O2 is converted
to hypochlorous acid (HOCl). HOCl is highly oxidative
and plays an important role in killing of the pathogens in
the airways.28 However, HOCl can also react with DNA and
induce DNA–protein interactions and produce pyrimidine
oxidation products and add chloride to DNA bases.29,30
Eosinophil peroxidase and MPO also contribute to the oxi-
dative stress by modiﬁcation of proteins by halogenations,
nitration, and protein cross-links via tyrosyl radicals.31–33
Other oxygen-derived free radicals are the peroxyl
radicals (ROO$). Simplest form of these radicals is hydro-
peroxyl radical (HOO$) and has a role in fatty acid perox-
idation. Free radicals can trigger lipid peroxidation chain
reactions by abstracting a hydrogen atom from a side-
chain methylene carbon. The lipid radical then reacts with
oxygen to produce peroxyl radical. Peroxyl radical initiates
a chain reaction and transforms polyunsaturated fatty acids
into lipid hydroperoxides. Lipid hydroperoxides are very
unstable and easily decompose to secondary products,
such as aldehydes (such as 4-hydroxy-2,3-nonenal) and
malondialdehydes (MDAs). Isoprostanes are another
group of lipid peroxidation products that are generated
via the peroxidation of arachidonic acid and have also
been found to be elevated in plasma and breath conden-
sates of asthmatics.34,35 Peroxidation of lipids disturbs the
integrity of cell membranes and leads to rearrangement of
membrane structure.
Hydrogen peroxide, superoxide radical, oxidized glu-
tathione (GSSG), MDAs, isoprostanes, carbonyls, and nitro-
tyrosine can be easily measured from plasma, blood, or
bronchoalveolar lavage samples as biomarkers of oxidation
by standardized assays.
Exogenous Source of Oxidants
Cigarette Smoke
Cigarette smoke contains many oxidants and free
radicals and organic compounds, such as superoxide and
nitric oxide.36 In addition, inhalation of cigarette smoke into
the lung also activates some endogenous mechanisms, such as
accumulation of neutrophils and macrophages, which further
increase the oxidant injury.
Ozone Exposure
Ozone exposure can cause lipid peroxidation and
induce inﬂux of neutrophils into the airway epithelium.
Short-term exposure to ozone also causes the release of
inﬂammatory mediators, such as MPO, eosinophil cationic
proteins and also lactate dehydrogenase and albumin.37 Even
in healthy subjects, ozone exposure causes a reduction in
pulmonary functions.38 Cho et al39 have shown that particu-
late matter (mixture of solid particles and liquid droplets sus-
pended in the air) catalyzes the reduction of oxygen.
Hyperoxia
Hyperoxia refers to conditions of higher oxygen levels
than normal partial pressure of oxygen in the lungs or other
body tissues. It leads to greater production of reactive oxygen
and nitrogen species.40,41
Ionizing Radiation
Ionizing radiation, in the presence of O2, converts
hydroxyl radical, superoxide, and organic radicals to hydro-
gen peroxide and organic hydroperoxides. These hydroper-
oxide species react with redox active metal ions, such as Fe
and Cu, via Fenton reactions and thus induce oxidative
stress.42,43 Narayanan et al44 showed that ﬁbroblasts that
were exposed to alpha particles had signiﬁcant increases
in intracellular O22. and H2O2 production via plasma
membrane-bound NADPH oxidase.44 Signal transduction
molecules, such as extracellular signal-regulated kinase
1 and 2 (ERK1/2), c-Jun N-terminal kinase (JNK), and
p38, and transcription factors, such as activator protein-1
(AP-1), nuclear factor-kB (NF-kB), and p53, are activated,
which result in the expression of radiation response–related
genes.45–50 Ultraviolet A (UVA) photons trigger oxidative
reactions by excitation of endogenous photosensitizers, such
as porphyrins, NADPH oxidase, and riboﬂavins. 8-Oxo-7,8-
dihydroguanine (8-oxoGua) is the main UVA-mediated
DNA oxidation product formed by the oxidation of OH
radical, 1-electron oxidants, and singlet oxygen that mainly
reacts with guanine.51 The formation of guanine radical cat-
ion in isolated DNA has been shown to efﬁciently occur
through the direct effect of ionizing radiation.52,53 After
exposure to ionizing radiation, intracellular level of
TABLE 1. Major Endogenous Oxidants
Oxidant Formula Reaction Equation
Superoxide anion O22. NADPH 1 2O24 NADP1 1 2O22. 1 H1
2O22. 1 H1/ O2 1 H2O2
Hydrogen peroxide H2O2 Hypoxanthine 1 H2O 1 O2# xanthine 1 H2O2
Xanthine 1 H2O 1 O2# uric acid 1 H2O2
Hydroxyl radical OH Fe21 1 H2O2/ Fe31 1 OH2 1 OH
Hypochlorous acid HOCl H2O2 1 Cl2/ HOCl 1 H2O
Peroxyl radicals ROO R 1 O2/ ROO
Hydroperoxyl radical HOO$ O22 1 H2O# HOO$ 1 OH2
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glutathione (GSH) decreases for a short term but then
increases again.54
Heavy Metal Ions
Heavy metal ions, such as iron, copper, cadmium,
mercury, nickel, lead, and arsenic, can induce generation of
reactive radicals and cause cellular damage via depletion of
enzyme activities through lipid peroxidation and reaction with
nuclear proteins and DNA.55
One of the most important mechanisms of metal-
mediated free radical generation is via a Fenton-type reaction.
Superoxide ion and hydrogen peroxide can interact with
transition metals, such as iron and copper, via the metal




31 1OH2 1 $OH Fenton reaction
Besides the Fenton-type and Haber–Weiss-type mech-
anisms, certain metal ions can react directly with cellular
molecules to generate free radicals, such as thiol radicals, or
induce cell signaling pathways. These radicals may also react
with other thiol molecules to generate O22.. O22. is converted
to H2O2, which causes additional oxygen radical generation.
Some metals, such as arsenite, induce ROS formation indi-
rectly by activation of radical producing systems in cells.56
Arsenic is a highly toxic element that produces
a variety of ROS, including superoxide (O22), singlet
oxygen (1O2), peroxyl radical (ROO), nitric oxide (NO),
hydrogen peroxide (H2O2), and dimethylarsinic peroxyl
radicals [(CH3)2AsOO].
57–59 Arsenic (III) compounds can
inhibit antioxidant enzymes, especially the GSH-dependent
enzymes, such as glutathione-S-transferases (GSTs), gluta-
thione peroxidase (GSH-Px), and GSH reductase, via bind-
ing to their sulfhydryl (–SH) groups.60,61
Lead increases lipid peroxidation.62 Signiﬁcant
decreases in the activity of tissue SOD and brain GPx have
been reported after lead exposure.63,64 Replacement of zinc,
which serves as a cofactor for many enzymes by lead, leads
to inactivation of such enzymes. Lead exposure may cause
inhibition of GST by affecting tissue thiols.
ROS generated by metal-catalyzed reactions can mod-
ify DNA bases. Three base substitutions, G / C, G / T,
and C / T, can occur as a result of oxidative damage by
metal ions, such as Fe21, Cu21, and Ni21. Reid et al65
showed that G / C was predominantly produced by Fe21
while C/ T substitution was by Cu21 and Ni21.
ANTIOXIDANTS
The human body is equipped with a variety of antiox-
idants that serve to counterbalance the effect of oxidants. For
all practical purposes, these can be divided into 2 categories:
enzymatic (Table 2) and nonenzymatic (Table 3).
Enzymatic Antioxidants
The major enzymatic antioxidants of the lungs are
SODs (EC 1.15.1.11), catalase (EC 1.11.1.6), and GSH-Px
(EC 1.11.1.9). In addition to these major enzymes, other
antioxidants, including heme oxygenase-1 (EC 1.14.99.3),
and redox proteins, such as thioredoxins (TRXs, EC
1.8.4.10), peroxiredoxins (PRXs, EC 1.11.1.15), and gluta-
redoxins, have also been found to play crucial roles in the
pulmonary antioxidant defenses.
Since superoxide is the primary ROS produced from
a variety of sources, its dismutation by SOD is of primary
importance for each cell. All 3 forms of SOD, that is, CuZn-
SOD, Mn-SOD, and EC-SOD, are widely expressed in the
human lung. Mn-SOD is localized in the mitochondria
matrix. EC-SOD is primarily localized in the extracellular
matrix, especially in areas containing high amounts of type I
collagen ﬁbers and around pulmonary and systemic vessels. It
has also been detected in the bronchial epithelium, alveolar
epithelium, and alveolar macrophages.66,67 Overall, CuZn-
SOD and Mn-SOD are generally thought to act as bulk scav-
engers of superoxide radicals. The relatively high EC-SOD
level in the lung with its speciﬁc binding to the extracellular
matrix components may represent a fundamental component
of lung matrix protection.68
H2O2 that is produced by the action of SODs or the
action of oxidases, such as xanthine oxidase, is reduced to
TABLE 2. Enzymatic Scavenger of Antioxidant Defense
Name of Scavenger Acronym Catalyzed Reaction
Superoxide dismutase SOD M(n11)1-SOD 1 O22/ Mn1-SOD 1 O2
Mn1-SOD 1 O22 1 2H1/ M(n11)1-SOD 1 H2O2
Catalase CAT 2 H2O2/ O2 1 2 H2O
H2O2 1 Fe(III)-E/ H2O 1 O ¼ Fe(IV)-E(.1)
H2O2 1 O ¼ Fe(IV)-E(.1)/ H2O 1 Fe(III)-E 1 O2
Glutathione peroxidase GTPx 2GSH 1H2O2/ GSSG 12H2O
2GSH1 ROOH/ GSSG 1 ROH 1 H2O
Thioredoxin TRX Adenosine monophosphate 1 sulﬁte 1 thioredoxin
disulﬁde ¼ 5’-adenylyl sulfate 1 thioredoxin
Adenosine 39,59-bisphosphate 1 sulﬁte 1 thioredoxin
disulﬁde ¼ 39-phosphoadenylyl sulfate 1 thioredoxin
Peroxiredoxin PRX 2 R9-SH 1 ROOH ¼ R9-S-S-R9 1 H2O 1 ROH
Glutathione transferase GST RX 1 GSH ¼ HX 1 R-S-GSH
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water by catalase and the GSH-Px. Catalase exists as a tetra-
mer composed of 4 identical monomers, each of which con-
tains a heme group at the active site. Degradation of H2O2 is
accomplished via the conversion between 2 conformations of
catalase-ferricatalase (iron coordinated to water) and com-
pound I (iron complexed with an oxygen atom). Catalase also
binds NADPH as a reducing equivalent to prevent oxidative
inactivation of the enzyme (formation of compound II) by
H2O2 as it is reduced to water.
69
Enzymes in the redox cycle responsible for the reduction
of H2O2 and lipid hydroperoxides (generated as a result of
membrane lipid peroxidation) include the GSH-Pxs.70 The
GSH-Pxs are a family of tetrameric enzymes that contain the
unique amino acid selenocysteine within the active sites and
use low-molecular-weight thiols, such as GSH, to reduce H2O2
and lipid peroxides to their corresponding alcohols. Four GSH-
Pxs have been described, encoded by different genes: GSH-
Px-1 (cellular GSH-Px) is ubiquitous and reduces H2O2 and
fatty acid peroxides, but not esteriﬁed peroxyl lipids.71 Esteri-
ﬁed lipids are reduced by membrane-bound GSH-Px-4 (phos-
pholipid hydroperoxide GSH-Px), which can use several
different low-molecular-weight thiols as reducing equiva-
lents. GSH-Px-2 (gastrointestinal GSH-Px) is localized in
gastrointestinal epithelial cells where it serves to reduce
dietary peroxides.72 GSH-Px-3 (extracellular GSH-Px) is
the only member of the GSH-Px family that resides in the
extracellular compartment and is believed to be one of the
most important extracellular antioxidant enzyme in mam-
mals. Of these, extracellular GSH-Px is most widely inves-
tigated in the human lung.73
In addition, disposal of H2O2 is closely associated with
several thiol-containing enzymes, namely, TRXs (TRX1 and
TRX2), thioredoxin reductases (EC 1.8.1.9) (TRRs), PRXs
(which are thioredoxin peroxidases), and glutaredoxins.74
Two TRXs and TRRs have been characterized in human cells,
existing in both cytosol and mitochondria. In the lung, TRX
and TRR are expressed in bronchial and alveolar epithelium
and macrophages. Six different PRXs have been found in hu-
man cells, differing in their ultrastructural compartmentaliza-
tion. Experimental studies have revealed the importance of
PRX VI in the protection of alveolar epithelium. Human lung
expresses all PRXs in bronchial epithelium, alveolar epithe-
lium, and macrophages.75 PRX V has recently been found to
function as a peroxynitrite reductase,76 which means that it
may function as a potential protective compound in the
development of ROS-mediated lung injury.77
Common to these antioxidants is the requirement of
NADPH as a reducing equivalent. NADPH maintains catalase
in the active form and is used as a cofactor by TRX and GSH
reductase (EC 1.6.4.2), which converts GSSG to GSH, a
co-substrate for the GSH-Pxs. Intracellular NADPH, in turn, is
generated by the reduction of NADP1 by glucose-6-phosphate
dehydrogenase, the ﬁrst and rate-limiting enzyme of the pen-
tose phosphate pathway, during the conversion of glucose-
6-phosphate to 6-phosphogluconolactone. By generating
NADPH, glucose-6-phosphate dehydrogenase is a critical
determinant of cytosolic GSH buffering capacity (GSH/
GSSG) and, therefore, can be considered an essential, regula-
tory antioxidant enzyme.78,79
GSTs (EC 2.5.1.18), another antioxidant enzyme
family, inactivate secondary metabolites, such as unsatu-
rated aldehydes, epoxides, and hydroperoxides. Three
major families of GSTs have been described: cytosolic
GST, mitochondrial GST,80,81 and membrane-associated
microsomal GST that has a role in eicosanoid and GSH
metabolism.82 Seven classes of cytosolic GST are identi-
ﬁed in mammalian, designated Alpha, Mu, Pi, Sigma, Theta,
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Mu and Pi GSTs interact with kinases Ask1 and JNK,
respectively, and inhibit these kinases.87–89 It has been shown
that GSTP1 dissociates from JNK in response to oxidative
stress.89 GSTP1 also physically interacts with PRX VI and
leads to recovery of PRX enzyme activity via glutathionylation
of the oxidized protein.90
Nonenzymatic Antioxidants
Nonenzymatic antioxidants include low-molecular-weight
compounds, such as vitamins (vitamins C and E), b-carotene,
uric acid, and GSH, a tripeptide (L-g-glutamyl-L-cysteinyl-L-
glycine) that comprise a thiol (sulfhydryl) group.
Vitamin C (Ascorbic Acid)
Water-soluble vitamin C (ascorbic acid) provides
intracellular and extracellular aqueous-phase antioxidant
capacity primarily by scavenging oxygen free radicals. It
converts vitamin E free radicals back to vitamin E. Its
plasma levels have been shown to decrease with age.91,92
Vitamin E (a-Tocopherol)
Lipid-soluble vitamin E is concentrated in the hydro-
phobic interior site of cell membrane and is the principal
defense against oxidant-induced membrane injury. Vitamin E
donates electron to peroxyl radical, which is produced during
lipid peroxidation. a-Tocopherol is the most active form of
vitamin E and the major membrane-bound antioxidant in cell.
Vitamin E triggers apoptosis of cancer cells and inhibits free
radical formations.93
Glutathione
GSH is highly abundant in all cell compartments and is
the major soluble antioxidant. GSH/GSSG ratio is a major
determinant of oxidative stress. GSH shows its antioxidant
effects in several ways.94 It detoxiﬁes hydrogen peroxide and
lipid peroxides via action of GSH-Px. GSH donates its elec-
tron to H2O2 to reduce it into H2O and O2. GSSG is again
reduced into GSH by GSH reductase that uses NAD(P)H as
the electron donor. GSH-Pxs are also important for the pro-
tection of cell membrane from lipid peroxidation. Reduced
glutathione donates protons to membrane lipids and protects
them from oxidant attacks.95
GSH is a cofactor for several detoxifying enzymes,
such as GSH-Px and transferase. It has a role in converting
vitamin C and E back to their active forms. GSH protects
cells against apoptosis by interacting with proapoptotic and
antiapoptotic signaling pathways.94 It also regulates and
activates several transcription factors, such as AP-1, NF-kB,
and Sp-1.
Carotenoids (b-Carotene)
Carotenoids are pigments found in plants. Primarily,
b-carotene has been found to react with peroxyl (ROO),
hydroxyl (OH), and superoxide (O22.) radicals.96 Carote-
noids show their antioxidant effects in low oxygen partial
pressure but may have pro-oxidant effects at higher oxygen
concentrations.97 Both carotenoids and retinoic acids (RAs)
are capable of regulating transcription factors.98 b-Carotene
inhibits the oxidant-induced NF-kB activation and interleukin
(IL)-6 and tumor necrosis factor-a production. Carotenoids
also affect apoptosis of cells. Antiproliferative effects of RA
have been shown in several studies. This effect of RA is
mediated mainly by retinoic acid receptors and vary among
cell types. In mammary carcinoma cells, retinoic acid receptor
was shown to trigger growth inhibition by inducing cell cycle
arrest, apoptosis, or both.99,100
THE EFFECT OF OXIDATIVE STRESS: GENETIC,
PHYSIOLOGICAL, AND
BIOCHEMICAL MECHANISMS
Oxidative stress occurs when the balance between
antioxidants and ROS are disrupted because of either
depletion of antioxidants or accumulation of ROS. When
oxidative stress occurs, cells attempt to counteract the
oxidant effects and restore the redox balance by activation
or silencing of genes encoding defensive enzymes, tran-
scription factors, and structural proteins.101,102 Ratio
between oxidized and reduced glutathione (2GSH/GSSG)
is one of the important determinants of oxidative stress in
the body. Higher production of ROS in body may change
DNA structure, result in modiﬁcation of proteins and lipids,
activation of several stress-induced transcription factors,
and production of proinﬂammatory and anti-inﬂammatory
cytokines.
Effects of Oxidative Stress on DNA
ROS can lead to DNA modiﬁcations in several ways,
which involves degradation of bases, single- or double-
stranded DNA breaks, purine, pyrimidine or sugar-bound
modiﬁcations, mutations, deletions or translocations, and
cross-linking with proteins. Most of these DNA modiﬁcations
(Fig. 1) are highly relevant to carcinogenesis, aging, and neu-
rodegenerative, cardiovascular, and autoimmune diseases.
Tobacco smoke, redox metals, and nonredox metals, such
as iron, cadmium, chrome, and arsenic, are also involved in
carcinogenesis and aging by generating free radicals or bind-
ing with thiol groups. Formation of 8-OH-G is the best-
known DNA damage occurring via oxidative stress and is
a potential biomarker for carcinogenesis.
Promoter regions of genes contain consensus sequences
for transcription factors. These transcription factor–binding
sites contain GC-rich sequences that are susceptible for oxi-
dant attacks. Formation of 8-OH-G DNA in transcription
factor binding sites can modify binding of transcription fac-
tors and thus change the expression of related genes as has
been shown for AP-1 and Sp-1 target sequences.103 Besides
8-OH-G, 8,59-cyclo-29-deoxyadenosine (cyclo-dA) has also
been shown to inhibit transcription from a reporter gene in
a cell system if located in a TATA box.104 The TATA-binding
protein initiates transcription by changing the bending of
DNA. The binding of TATA-binding protein may be impaired
by the presence of cyclo-dA.
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Oxidative stress causes instability of microsatellite
(short tandem repeats) regions. Redox active metal ions,
hydroxyl radicals increase microsatellite instability.105 Even
though single-stranded DNA breaks caused by oxidant injury
can easily be tolerated by cells, double-stranded DNA breaks
induced by ionizing radiation can be a signiﬁcant threat for
the cell survival.106
Methylation at CpG islands in DNA is an important
epigenetic mechanism that may result in gene silencing.
Oxidation of 5-MeCyt to 5-hydroxymethyl uracil (5-OHMeUra)
can occur via deamination/oxidation reactions of thymine or
5-hydroxymethyl cytosine intermediates.107 In addition to the
modulating gene expression, DNA methylation also seems to
affect chromatin organization.108 Aberrant DNA methylation
patterns induced by oxidative attacks also affect DNA repair
activity.
Effects of Oxidative Stress on Lipids
ROS can induce lipid peroxidation and disrupt the
membrane lipid bilayer arrangement that may inactivate
membrane-bound receptors and enzymes and increase tissue
permeability.109 Products of lipid peroxidation, such as MDA
and unsaturated aldehydes, are capable of inactivating many
cellular proteins by forming protein cross-linkages.110–112
4-Hydroxy-2-nonenal causes depletion of intracellular
GSH and induces of peroxide production,113,114 activates
epidermal growth factor receptor,115 and induces ﬁbronectin
production.116 Lipid peroxidation products, such as isopros-
tanes and thiobarbituric acid reactive substances, have been
used as indirect biomarkers of oxidative stress, and incre-
ased levels were shown in the exhaled breath condensate or
bronchoalveolar lavage ﬂuid or lung of chronic obstructive
pulmonary disease patients or smokers.117–119
Effects of Oxidative Stress on Proteins
ROS can cause fragmentation of the peptide chain,
alteration of electrical charge of proteins, cross-linking of
proteins, and oxidation of speciﬁc amino acids and therefore
lead to increased susceptibility to proteolysis by degradation
by speciﬁc proteases.120 Cysteine and methionine residues
in proteins are particularly more susceptible to oxidation.121
Oxidation of sulfhydryl groups or methionine residues of
proteins cause conformational changes, protein unfolding,
and degradation.8,121–123 Enzymes that have metals on or
close to their active sites are especially more sensitive to
metal catalyzed oxidation. Oxidative modiﬁcation of enzymes
has been shown to inhibit their activities.124,125
In some cases, speciﬁc oxidation of proteins may take
place. For example, methionine can be oxidized methionine
sulfoxide126 and phenylalanine to o-tyrosine127; sulfhydryl
groups can be oxidized to form disulﬁde bonds;128 and car-
bonyl groups may be introduced into the side chains of pro-
teins. Gamma rays, metal-catalyzed oxidation, HOCl, and
ozone can cause formation of carbonyl groups.129
Effects of Oxidative Stress on
Signal Transduction
ROS can induce expression of several genes involved
in signal transduction.1,130 A high ratio for GSH/GSSG is
important for the protection of the cell from oxidative dam-
age. Disruption of this ratio causes activation of redox sensi-
tive transcription factors, such as NF-kB, AP-1, nuclear factor
of activated T cells and hypoxia-inducible factor 1 , that are
involved in the inﬂammatory response. Activation of tran-
scription factors via ROS is achieved by signal transduction
cascades that transmit the information from outside to the
inside of cell. Tyrosine kinase receptors, most of the growth
factor receptors, such as epidermal growth factor receptor,
vascular endothelial growth factor receptor, and receptor for
platelet-derived growth factor, protein tyrosine phosphatases,
and serine/threonine kinases are targets of ROS.131–133 Extra-
cellular signal-regulated kinases, JNK, and p38, which are
the members of mitogen-activated protein kinase family and
involved in several processes in cell including proliferation,
differentiation, and apoptosis, also can be regulated by oxidants.
Under oxidative stress conditions, cysteine residues in
the DNA-binding site of c-Jun, some AP-1 subunits, and
FIGURE 1. Base modifications
introduced by reactive oxygen
species.
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inhibitory k-B kinase undergo reversible S-glutathiolation.
Glutaredoxin and TRX have been reported to play an impor-
tant role in regulation of redox-sensitive signaling pathways,
such as NF-kB and AP-1, p38 mitogen-activated protein
kinase, and JNK.134–137
NF-kB can be activated in response to oxidative stress
conditions, such as ROS, free radicals, and UV irradiation.138
Phosphorylation of IkB frees NF-kB and allows it to enter the
nucleus to activate gene transcription.139 A number of kinases
have been reported to phosphorylate IkBs at the serine resi-
dues. These kinases are the targets of oxidative signals for
activation of NF-kB.140 Reducing agents enhance NF-kB
DNA binding, whereas oxidizing agents inhibit DNA binding
of NF-kB. TRX may exert 2 opposite actions in regulation of
NF-kB: in the cytoplasm, it blocks degradation of IkB and
inhibits NF-kB activation but enhances NF-kB DNA binding
in the nucleus.141 Activation of NF-kB via oxidation-related
degradation of IkB results in the activation of several antiox-
idant defense–related genes. NF-kB regulates the expression
of several genes that participate in immune response, such as
IL-1b, IL-6, tumor necrosis factor-a, IL-8, and several adhe-
sion molecules.142,143 NF-kB also regulates angiogenesis and
proliferation and differentiation of cells.
AP-1 is also regulated by redox state. In the presence
of H2O2, some metal ions can induce activation of AP-1.
Increase in the ratio of GSH/GSSG enhances AP-1 binding
while GSSG inhibits the DNA binding of AP-1.144 DNA
binding of the Fos/Jun heterodimer is increased by the
reduction of a single conserved cysteine in the DNA-binding
domain of each of the proteins,145 while DNA binding of
AP-1 can be inhibited by GSSG in many cell types, suggest-
ing that disulphide bond formation by cysteine residues
inhibits AP-1 DNA binding.146,147 Signal transduction via
oxidative stress is summarized in Figure 2.
CONCLUSIONS
Oxidative stress can arise from overproduction of ROS
by metabolic reactions that use oxygen and shift the balance
between oxidant/antioxidant statuses in favor of the oxidants.
ROS are produced by cellular metabolic activities and
environmental factors, such as air pollutants or cigarette
smoke. ROS are highly reactive molecules because of
unpaired electrons in their structure and react with several
biological macromolecules in cell, such as carbohydrates,
nucleic acids, lipids, and proteins, and alter their functions.
ROS also affects the expression of several genes by
upregulation of redox-sensitive transcription factors and
chromatin remodeling via alteration in histone acetylation/
deacetylation. Regulation of redox state is critical for cell
viability, activation, proliferation, and organ function.
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